BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB)
CUSIP: 09077B104
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Common Stocks, par value $0,0001 per share
- Shares outstanding
- 58,548,563
- Total 13F shares
- 105,237
- Share change
- -5,782
- Total reported value
- $16,776
- Price per share
- $0.16
- Number of holders
- 4
- Value change
- -$21,280
- Number of buys
- 1
- Number of sells
- 4
Quarterly Holders Quick Answers
What is CUSIP 09077B104?
CUSIP 09077B104 identifies BCAB - BioAtla, Inc. - Common Stocks, par value $0,0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Previous quarter: Q4 2025
Recent filing periods for CUSIP 09077B104:
Top shareholders of BCAB - BioAtla, Inc. - Common Stocks, par value $0,0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Guy Levy |
3/4/5
|
Former Director |
—
class O/S missing
|
1,130,688
|
$2,781,493 | — | 16 Jun 2022 | |
| ACORN CAPITAL ADVISORS, LLC |
13F
|
Company |
8.3%
|
4,835,111
|
$2,756,013 | — | 31 Dec 2025 | |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC |
13D/G
|
— |
7.7%
|
4,839,579
|
$2,129,415 | -$1,104,235 | 31 Mar 2025 | |
| ACORN BIOVENTURES, L.P. |
13D/G
|
Anders Hove |
8.3%
|
4,835,111
|
$2,127,449 | $0 | 15 May 2025 | |
| OPOKA INVESTMENT FUND Co |
13D/G
|
— |
4.8%
|
2,810,331
|
$1,933,227 | -$507,296 | 09 Jul 2025 | |
| Jay M. Short PhD |
13D/G
3/4/5
|
Jay M. Short · Chief Executive Officer, Director |
6.6%
|
3,865,646
|
$1,700,884 | $0 | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.3%
|
1,945,795
|
$1,105,212 | — | 31 Dec 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
1.5%
|
891,580
|
$508,201 | — | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13D/G
13F
|
Company |
1.9%
|
1,095,606
|
$482,067 | $0 | 31 Dec 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
1.3%
|
757,671
|
$429,000 | — | 31 Dec 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.2%
|
707,214
|
$401,485 | — | 31 Dec 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.9%
|
525,353
|
$299,451 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.85%
|
500,328
|
$284,096 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.82%
|
480,933
|
$273,026 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.59%
|
346,774
|
$196,863 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.39%
|
225,684
|
$128,188 | — | 31 Dec 2025 | |
| Scott Andrew Smith |
3/4/5
|
Director |
0.55%
|
321,550
|
$125,404 | — | 18 Jun 2025 | |
| Eric Sievers |
3/4/5
|
Chief Medical Officer |
1%
|
598,705
|
$107,766 | — | 10 Mar 2026 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.31%
|
183,107
|
$103,950 | — | 31 Dec 2025 | |
| Christian Vasquez |
3/4/5
|
Chief Financial Officer |
0.91%
|
530,196
|
$95,435 | — | 10 Mar 2026 | |
| STATE STREET CORP |
13F
|
Company |
0.26%
|
151,377
|
$85,937 | — | 31 Dec 2025 | |
| Richard A. Waldron |
3/4/5
|
Former Chief Financial Officer |
0.59%
|
343,421
|
$84,824 | — | 28 Feb 2026 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.21%
|
120,391
|
$68,382 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.18%
|
103,494
|
$58,754 | — | 31 Dec 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.14%
|
81,687
|
$46,373 | — | 31 Dec 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.14%
|
81,330
|
$46,171 | — | 31 Dec 2025 | |
| PVG ASSET MANAGEMENT CORP |
13F
|
Company |
0.12%
|
69,000
|
$39,171 | — | 31 Dec 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.1%
|
60,395
|
$34,286 | — | 31 Dec 2025 | |
| Virtu Financial LLC |
13F
|
Company |
0.09%
|
55,460
|
$31,000 | — | 31 Dec 2025 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.09%
|
54,742
|
$31,000 | — | 31 Dec 2025 | |
| Lawrence Steinman |
3/4/5
|
Director |
0.13%
|
78,459
|
$30,599 | — | 18 Jun 2025 | |
| Mary Ann Gray |
3/4/5
|
Director |
0.13%
|
77,397
|
$30,184 | — | 18 Jun 2025 | |
| MAI Capital Management |
13F
|
Company |
0.09%
|
51,504
|
$29,239 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.07%
|
43,653
|
$24,781 | — | 31 Dec 2025 | |
| Eddie Williams |
3/4/5
|
Director |
0.1%
|
60,200
|
$23,478 | — | 18 Jun 2025 | |
| Sylvia McBrinn |
3/4/5
|
Director |
0.1%
|
59,125
|
$23,058 | — | 18 Jun 2025 | |
| Susan Moran |
3/4/5
|
Director |
0.09%
|
52,307
|
$20,399 | — | 18 Jun 2025 | |
| COLUMBIA ADVISORY PARTNERS LLC |
13F
|
Company |
0.04%
|
26,070
|
$14,800 | — | 31 Dec 2025 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.04%
|
25,300
|
$14,360 | — | 31 Dec 2025 | |
| Magnus Financial Group LLC |
13F
|
Company |
0.03%
|
20,000
|
$11,354 | — | 31 Dec 2025 | |
| Torrey Growth & Income Advisors |
13F
|
Company |
0.03%
|
15,687
|
$8,942 | — | 31 Dec 2025 | |
| Global Wealth Strategies & Associates |
13F
|
Company |
0.02%
|
13,769
|
$7,817 | — | 31 Dec 2025 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.02%
|
13,000
|
$7,380 | — | 31 Dec 2025 | |
| Twin Lakes Capital Management, LLC |
13F
|
Company |
0.02%
|
9,000
|
$5,109 | — | 31 Dec 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0.02%
|
8,790
|
$4,990 | — | 31 Dec 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
5,318
|
$3,019 | — | 31 Dec 2025 | |
| JONES FINANCIAL COMPANIES LLLP |
13F
|
Company |
0%
|
2,000
|
$1,134 | — | 31 Dec 2025 | |
| ARCADIA INVESTMENT MANAGEMENT CORP/MI |
13F
|
Company |
0%
|
1,403
|
$797 | — | 31 Dec 2025 | |
| CIBC Private Wealth Group LLC |
13F
|
Company |
0%
|
1,290
|
$732 | — | 31 Dec 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
500
|
$285 | — | 31 Dec 2025 |
Institutional Holders of BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) as of Q1 2026
As of 31 Mar 2026,
BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) was held by
4 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
105,237 shares.
The largest 4 holders included
Kestra Advisory Services, LLC, COMMONWEALTH EQUITY SERVICES, LLC, Magnus Financial Group LLC, and Torrey Growth & Income Advisors.
This page lists
4
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
40
Q1 2026 holders
4
Holder diff
-36
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.